LUX-Lung
Sequist, L., et al., Subsequent therapies post- afatinib among patients (pts) with EGFR mutation- positive (EGFRm+) NSCLC in LUX-Lung (LL) 3, 6 and 7.
Sequist, L ., et al ., Subsequent therapies post- afatinib among patients ( pts ) with EGFR mutation- positive ( EGFRm+ ) NSCLC in LUX-Lung ( LL ) 3, 6 and 7 .